What every line of a peptide Certificate of Analysis actually means, and the checks an Australian research lab should run before trusting one.
A Certificate of Analysis (COA) is the single document that separates a verifiable research peptide from an unverifiable one. Almost every supplier now attaches a PDF labelled 'Certificate of Analysis' to a product listing, but not every COA is produced by an independent laboratory, and not every COA covers the parameters that actually matter for research validity. This guide walks through a COA line by line so an Australian research team can tell the difference between genuine third-party verification and a document that simply looks official.
The batch or lot identifier
Every legitimate COA starts with a batch or lot number. This is not a formality — it is the link between the physical vial in your freezer and the specific analytical run that produced the rest of the document. Before logging any peptide into a study, confirm the batch number printed on the vial matches the number on the COA exactly. A COA with no batch number, or a generic COA reused across multiple product listings, cannot be trusted as evidence for that specific vial.
HPLC purity
High-Performance Liquid Chromatography (HPLC) purity is usually the first number researchers look at, and for good reason — it quantifies what proportion of the material in the vial is the intended peptide versus synthesis by-products, truncated sequences, or degradation fragments. Research-grade peptides are typically expected to report ≥98% purity, with several compounds such as BPC-157 commonly verified at ≥99%. A COA reporting purity without stating the chromatographic method (RP-HPLC, wavelength used) or without a visible chromatogram trace is weaker evidence than one that includes both.
Mass spectrometry identity confirmation
Purity alone does not confirm identity — a sample can be 99% pure and still be the wrong peptide entirely. This is what mass spectrometry (LC-MS or MALDI-TOF) is for: it confirms the molecular mass of the dominant species in the vial matches the theoretical mass of the labelled compound, typically within a tolerance of ±0.5 Da. A COA should state the observed mass next to the theoretical mass so the match is directly checkable.
| Compound | Theoretical Mass | Acceptable Match Tolerance |
|---|---|---|
| BPC-157 | 1419.5 Da | ± 0.5 Da |
| Semaglutide | 4113.6 Da | ± 0.5 Da |
| Tirzepatide | 4813.45 Da | ± 0.5 Da |
| Retatrutide | 4731 Da | ± 0.5 Da |
Counterion identity and content
Synthetic peptides are typically supplied as a salt — most commonly the acetate or trifluoroacetate (TFA) salt form. The counterion contributes measurable mass to the vial contents without being part of the active peptide, so a COA should state both the counterion identity and its approximate percentage. This matters for any study calculating effective peptide concentration from total vial weight.
Endotoxin and residual solvents
For any research protocol involving cell culture work, bacterial endotoxin content is a critical parameter — elevated endotoxin can confound in-vitro signalling results entirely independent of the peptide itself. A rigorous COA reports endotoxin in EU/mg using a validated method such as LAL kinetic chromogenic testing. Residual solvents and water content (often measured by Karl Fischer titration) are also reported on more detailed COAs and matter most for hygroscopic or synthesis-sensitive compounds.
Independent verification versus in-house testing
The most important distinction a research buyer can make is between an in-house COA — produced by the same manufacturer that synthesised the peptide, with no independent oversight — and a COA verified by an accredited third-party laboratory. In-house documents are not inherently dishonest, but they carry an obvious conflict of interest. Independently verified testing removes that conflict and is the standard a research-grade supplier should be able to produce on request.
Quick COA verification checklist
- Confirm the batch number on the COA matches the vial exactly.
- Check RP-HPLC purity is stated with method and, ideally, a chromatogram.
- Confirm LC-MS mass matches the theoretical mass for that specific compound.
- Check counterion identity and percentage are disclosed.
- Look for endotoxin and residual solvent data if the material will touch cell culture work.
- Confirm whether testing was performed independently or in-house, and ask the supplier directly if it is not stated.
Frequently asked research questions
What is the difference between HPLC purity and mass spec identity?
HPLC purity measures how much of the vial contents is a single dominant species; mass spectrometry confirms that species is actually the labelled peptide by matching its molecular mass. A sample needs both to be considered verified.
Why does the batch number on my vial matter?
The batch number links the physical vial to the exact analytical run described in the Certificate of Analysis. Without a matching batch number, the COA is not verifiable evidence for that specific vial.
Is an in-house Certificate of Analysis reliable?
It can be directionally useful, but it lacks independent oversight. Third-party verified testing is the stronger standard for research-grade documentation.
Does every peptide need endotoxin testing on its COA?
It is most critical for compounds destined for cell culture or other endotoxin-sensitive in-vitro work; researchers should request this data specifically if their protocol requires it.
